Jeanine Superata

583 total citations
13 papers, 408 citations indexed

About

Jeanine Superata is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Jeanine Superata has authored 13 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Jeanine Superata's work include Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and CAR-T cell therapy research (3 papers). Jeanine Superata is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and CAR-T cell therapy research (3 papers). Jeanine Superata collaborates with scholars based in United States. Jeanine Superata's co-authors include Katayoun Rezvani, Agnes S. M. Yong, Bipin N. Savani, Behnam Jafarpour, A. John Barrett, Stephan Mielke, Carol Boss, Jennifer Lotter, Clare Sun and Pia Nierman and has published in prestigious journals such as Blood, British Journal of Haematology and Biology of Blood and Marrow Transplantation.

In The Last Decade

Jeanine Superata

11 papers receiving 404 citations

Peers

Jeanine Superata
Jeanine Superata
Citations per year, relative to Jeanine Superata Jeanine Superata (= 1×) peers Mette Ilander

Countries citing papers authored by Jeanine Superata

Since Specialization
Citations

This map shows the geographic impact of Jeanine Superata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanine Superata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanine Superata more than expected).

Fields of papers citing papers by Jeanine Superata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanine Superata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanine Superata. The network helps show where Jeanine Superata may publish in the future.

Co-authorship network of co-authors of Jeanine Superata

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanine Superata. A scholar is included among the top collaborators of Jeanine Superata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanine Superata. Jeanine Superata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Duncan, Brynn B., Jeanine Superata, Colin O. Wu, et al.. (2024). Treatment of refractory/relapsed Diamond–Blackfan anaemia with eltrombopag. British Journal of Haematology. 204(5). 2077–2085. 2 indexed citations
3.
Brofferio, Alessandra, Jeanine Superata, Susan Soto, et al.. (2024). Cardiac Monitoring of Patients on Btki for Chronic Lymphocytic Leukemia. Blood. 144(Supplement 1). 6787–6787.
4.
Duncan, Brynn B., Jennifer Lotter, Jeanine Superata, et al.. (2022). Treatment of Refractory Diamond-Blackfan Anemia with Eltrombopag. Blood. 140(Supplement 1). 5824–5825. 3 indexed citations
5.
Pleyer, Christopher, Kerry J. Laing, Mir A. Ali, et al.. (2022). BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL. Blood Advances. 6(6). 1732–1740. 18 indexed citations
6.
Pleyer, Christopher, Clare Sun, Inhye E. Ahn, et al.. (2020). Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors. Leukemia & lymphoma. 61(10). 2375–2382. 15 indexed citations
7.
Pleyer, Christopher, Mir A. Ali, Jeffrey I. Cohen, et al.. (2020). Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 137(2). 185–189. 84 indexed citations
10.
Ito, Sawa, Xin Tian, Keyvan Keyvanfar, et al.. (2017). Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(3). 460–466. 2 indexed citations
11.
Dunavin, Neil, Jeanine Superata, Quan Yu, et al.. (2017). Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia. Leukemia Research Reports. 7. 40–44. 4 indexed citations
12.
Rezvani, Katayoun, Agnes S. M. Yong, Stephan Mielke, et al.. (2007). Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood. 111(1). 236–242. 261 indexed citations
13.
Rezvani, Katayoun, Agnes S. M. Yong, Stephan Mielke, et al.. (2007). Leukemia-Associated Antigen Specific T-Cell Responses Following Combined PR1 and WT1 Peptide Vaccination in Patients with Myeloid Malignancies.. Blood. 110(11). 287–287. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026